Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?

被引：4

作者：

Guapillo, Carolina ^{[1
]}

Hernandez-Pando, Rogelio ^{[1
]}

Alberto Flores-Valdez, Mario ^{[2
]}

机构：

[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Secc Patol Expt, Mexico City, DF, Mexico

[2] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Biotecnol Med & Farmaceut, Ave Normalistas 800, Guadalajara 44270, Jalisco, Mexico

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2016年 / 12卷 / 05期

关键词：

clinical trials; multiantigenic; tuberculosis; vaccines; MYCOBACTERIUM-TUBERCULOSIS; NEGATIVE ADULTS; IMMUNOGENICITY; MTB72F/AS02; ANTIGENS; HUMANS; SAFETY;

D O I：

10.1080/21645515.2015.1136760

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The idea of presenting this commentary is to bring attention to the current status of clinical tests from several multiantigen vaccine candidates based on proteins produced by means of genetic engineering and molecular biology approaches and to suggest how new emerging technologies (OMICs) and bioinformatics might benefit vaccine development for better control of tuberculosis.

引用

页码：1193 / 1195

页数：3

共 50 条

[21] Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?
Castano, Roberto
Malo, Jean-Luc
CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 10 (02) : 135 - 142
[22] RED ALGAL SPECIES: WHERE DO WE STAND, WHERE DO WE GO?
Zuccarello, G. C.
PHYCOLOGIA, 2013, 52 (04) : 127 - 128
[23] Breast Cancer in India: Where Do We Stand and Where Do We Go?
Khokhar, Anita
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 4861 - 4866
[24] Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?
Roberto Castano
Jean-Luc Malo
Current Allergy and Asthma Reports, 2010, 10 : 135 - 142
[25] Household stockholding in Europe: where do we stand and where do we go?
Guiso, L
Haliassos, M
Jappelli, T
Claessens, S
ECONOMIC POLICY, 2003, (36) : 123 - 170
[26] Rabies vaccines: where do we stand, where are we heading?
Kaur, Manpreet
Garg, Rajni
Singh, Samer
Bhatnagar, Rakesh
EXPERT REVIEW OF VACCINES, 2015, 14 (03) : 369 - 381
[27] Where do we stand with Randomized Clinical Trials?
Tognoni, Gianni
ASSISTENZA INFERMIERISTICA E RICERCA, 2016, 35 (04) : 197 - 201
[28] Clinical Trials in Myositis: Where Do We Stand?
Mann, Herman
Vencovsky, Jiri
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 222 - 242
[29] Clinical trials in sepsis: Where do we stand?
Vincent, JL
JOURNAL OF CRITICAL CARE, 1997, 12 (01) : 3 - 6
[30] Clinical Trials in Myositis: Where Do We Stand?
Heřman Mann
Jiří Vencovský
Current Treatment Options in Rheumatology, 2021, 7 : 222 - 242

← 1 2 3 4 5 →